Latest filing published 24 Jun 2026 for GSK plc, €39k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Dr Hal Dietz: trading record in brief
Dr Hal Dietz is a declared insider of GSK plc, with filings sourced from RNS (LSE). The record holds 13 filings, for trades running from 20 March 2024 to 22 June 2026.
On the market, this insider has only ever bought: 12 purchases, €190k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. In 2026 alone, the filings show 3 purchases and no sales.
Half of the purchases are above €11k and half below. Of 10 purchases, 10 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 24 June 2026: an open-market purchase of €39k, in GSK plc. Typically, a trade is published a median of 3 days after it takes place. For comparison, UK MAR gives managers three business days to notify a trade. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dr Hal Dietz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 667 shares@ £50.69080.0001% mcap95.3% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:9632737-4Canonical exit: 20 Sept 2026 (T+90)
- 667 shares@ £50.691221.7% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:1cabaef6-2e05-4f58-a412-24a2f7509642-4Canonical exit: 20 Sept 2026 (T+90)
- 196 shares@ £51.79596.6% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:c2055913-103f-4927-b6f8-8f0835af9e8e-5Canonical exit: 18 Jun 2026 (T+90)
- 201 shares@ £48.55726.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5a98a0c7-d756-450b-83e9-f26937fe1a0f-4Canonical exit: 19 Mar 2026 (T+90)
- 240 shares@ £40.73756.3% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5830475-5Canonical exit: 18 Dec 2025 (T+90)
- 257 shares@ £37.89499.7% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5708028-6Canonical exit: 18 Sept 2025 (T+90)
- 257 shares@ £37.89496.4% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5707630-6Canonical exit: 18 Sept 2025 (T+90)
- 850 shares@ £38.804722.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5593269-2
- 249 shares@ £39.27316.5% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5584787-6Canonical exit: 18 Jun 2025 (T+90)
- 271 shares@ £33.80816.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5479029-6Canonical exit: 20 Mar 2025 (T+90)
- 224 shares@ £41.01346.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5362280-5Canonical exit: 22 Dec 2024 (T+90)
- 225 shares@ £40.76446.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5235239-5Canonical exit: 18 Sept 2024 (T+90)
- 219 shares@ £41.90416.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5116598-6Canonical exit: 18 Jun 2024 (T+90)
13 of 13 declarations
